Rocklage Scott M's Form 4 filing
Pear Therapeutics, Inc. (PEAR) · filed Apr 12, 2023
- Accession no.
- 0001209191-23-024105
- Filed
- Apr 12, 2023, 4:51 PM ET
- Trade date
- Apr 10, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.99M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rocklage Scott MCIK 0001219014 | 10% Owner |
| Diekman John DCIK 0001240357 | 10% Owner |
| 5AM Partners IV, LLCCIK 0001589314 | 10% Owner |
| 5AM Ventures IV, L.P.CIK 0001589315 | 10% Owner |
| 5AM Co-Investors IV, L.P.CIK 0001593361 | 10% Owner |
| Schwab Andrew J.CIK 0001598549 | 10% Owner |
| 5AM Opportunities I, L.P.CIK 0001753000 | 10% Owner |
| 5AM Opportunities I (GP), LLCCIK 0001790778 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 10, 2023 | Class A Common Stock | SSaleDisposed | −12,836,489 | $0.12 | −$1,540,378.68 | 0 | Indirect | |
| Apr 10, 2023 | Class A Common Stock | SSaleDisposed | −534,855 | $0.12 | −$64,182.6 | 0 | Indirect | |
| Apr 10, 2023 | Class A Common Stock | SSaleDisposed | −3,172,769 | $0.12 | −$380,732.28 | 200,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.